Back to results
US 2024/0003888 A1Published application
Methods for identifying druggable targets and treating cancer
AssigneeGuardant Health, Inc.
InventorScott R. Bortner
Life of this patent
Estimating the term…
Abstract
This disclosure provides methods, sets, and kits for predicting and identifying druggable targets for treating cancer. This disclosure further provides methods of treating cancer.
Claims20
1-9. (canceled)
A method of selecting a targeted cancer diagnostic test for a subject, comprising:
- (a) performing or having performed a first test on a liquid biopsy sample of the subject to identify that the subject has a cancer, wherein the first test produces a first or second profile, optionally a first or second epigenetic profile, wherein the first profile is predictive of a first panel of one or more druggable targets in the subject and the second profile is predictive of a second panel of one or more druggable targets in the subject;
- and
- (b) selecting a second test as the targeted cancer diagnostic test, wherein:
- (i) if the first test produces the first profile, the second test assesses the presence or absence of the first panel of one or more druggable targets predicted by the first profile;
- and
- (ii) if the first test produces the second profile, the second test assesses the presence or absence of the second panel of one or more druggable targets predicted by the first profile.
3 more elements
(canceled)
-14. (canceled)
-45. (canceled)
Dependencies are inferred from the claim text.